Evidence map›Paper›PMID 38393898›Full record

ArticleJournal of Alzheimer's disease : JAD2024

Machine Learning Predicts Conversion from Normal Aging to Mild Cognitive Impairment Using Medical History, APOE Genotype, and Neuropsychological Assessment.

Divya Prabhakaran, Caroline Grant, Otto Pedraza, Richard Caselli, Arjun P Athreya, Melanie Chandler

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Divya PrabhakaranCenter for Individualized Medicine, Mayo Clinic, Jacksonville, FL, USA.
Caroline GrantDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
Otto PedrazaDepartment of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, USA.
Richard CaselliDepartment of Neurology, Mayo Clinic, Phoenix, AZ, USA.
Arjun P AthreyaDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
Melanie ChandlerCenter for Individualized Medicine, Mayo Clinic, Jacksonville, FL, USA.

Funding

Research Education ComponentP30AG072980 · NIA · BANNER HEALTH · PI HEATHER Allyson BIMONTE-NELSON · 2021 to 2026
$24.9M
Machine learning to predict incident MCI using standard clinical measuresR03AG070486 · NIA · MAYO CLINIC JACKSONVILLE · PI CHANDLER, MELANIE J · 2021 to 2021
$158k
NIA NIH HHS P30 AG072980NIA NIH HHS R03 AG070486
6 · The paper itself

Abstract

Background: Identifying individuals at risk for mild cognitive impairment (MCI) is of urgent clinical need. Objective: This study aimed to determine whether machine learning approaches could harness longitudinal neuropsychology measures, medical data, and APOEɛ4 genotype to identify individuals at risk of MCI 1 to 2 years prior to diagnosis. Methods: Data from 676 individuals who participated in the 'APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease' longitudinal study (N = 66 who converted to MCI) were utilized in supervised machine learning algorithms to predict conversion to MCI. Results: A random forest algorithm predicted conversion 1-2 years prior to diagnosis with 97% accuracy (p = 0.0026). The global minima (each individual's lowest score) of memory measures from the 'Rey Auditory Verbal Learning Test' and the 'Selective Reminding Test' were the strongest predictors. Conclusions: This study demonstrates the feasibility of using machine learning to identify individuals likely to convert from normal cognition to MCI.

Indexed as

Alzheimer DiseaseCognitive DysfunctionAgingApolipoproteins EDisease ProgressionGenotypeHumansLongitudinal StudiesMachine LearningNeuropsychological TestsApoE protein, humanApolipoproteins EAgingAlzheimer’s diseaseAPOEmachine learningmild cognitive impairmentneuropsychology

Identifiers

PMID38393898
PMCPMC11174347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.